Abstract
Reconstitution of the adaptive immune system following allogeneic hematopoietic stem cell transplantation is crucial for beneficial outcome and is affected by several factors, such as GvHD and graft source. The impact of these factors on immune reconstitution has been thoroughly investigated during the early phase after transplantation. However, little is known about their long-term effect. Similarly, leukocyte telomere length (TL) shortening has been reported shortly after transplantation. Nevertheless, whether TL shortening continues in long-term aspect is still unsettled. Here, we assessed T-cell receptor excision circle (TREC), kappa deleting recombination excision circle (KREC) and leukocyte TL in recipients and donors several years post transplantation (median 17 years). Our analysis showed that, recipients who received bone marrow (BM) as the graft source have higher levels of both TREC and KREC. Also, chronic GvHD affected TREC levels and TL but not KREC levels. Finally, we show that recipient’s TL was longer than respective donors in a group of young age recipients with high KREC levels. Our results suggest that BM can be beneficial for long-term adaptive immune recovery. We also present supporting evidence for recipient telomere homeostasis, especially in young age recipients, rather than telomere shortening.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Copelan EA . Hematopoietic stem-cell transplantation. N Engl j med 2006; 354: 1813–1826.
Minculescu L, Sengelov H . The role of gamma delta T cells in haematopoietic stem cell transplantation. Scand j immunol 2015; 81: 459–468.
Chen X, Hale GA, Barfield R, Benaim E, Leung WH, Knowles J et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br j haematol 2006; 135: 524–532.
Clave E, Busson M, Douay C, Peffault de Latour R, Berrou J, Rabian C et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009; 113: 6477–6484.
Clave E, Lisini D, Douay C, Giorgiani G, Busson M, Zecca M et al. Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse. Front immunol 2013; 4: 54.
Hazenberg MD, Otto SA, de Pauw ES, Roelofs H, Fibbe WE, Hamann D et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 2002; 99: 3449–3453.
Mensen A, Ochs C, Stroux A, Wittenbecher F, Szyska M, Imberti L et al. Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation. J transl med 2013; 11: 188.
Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000; 355: 1875–1881.
Jimenez M, Ercilla G, Martinez C . Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia 2007; 21: 1628–1637.
Jimenez M, Martinez C, Ercilla G, Carreras E, Urbano-Ispizua A, Aymerich M et al. Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults. Transplant immunol 2006; 16: 52–59.
Gaballa A, Sundin M, Stikvoort A, Abumaree M, Uzunel M, Sairafi D et al. T cell receptor excision circle (TREC) monitoring after allogeneic stem cell transplantation; a predictive marker for complications and clinical outcome. Int j mol sci 2016; 17: 1705.
Mensen A, Johrens K, Anagnostopoulos I, Demski S, Oey M, Stroux A et al. Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT. Blood 2014; 124: 963–972.
Townsley DM, Dumitriu B, Liu D, Biancotto A, Weinstein B, Chen C et al. Danazol treatment for telomere diseases. N Engl j med 2016; 374: 1922–1931.
Ruella M, Rocci A, Ricca I, Carniti C, Bodoni CL, Ladetto M et al. Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status. Bone marrow transplant 2010; 45: 505–512.
Akiyama M, Hoshi Y, Sakurai S, Yamada H, Yamada O, Mizoguchi H . Changes of telomere length in children after hematopoietic stem cell transplantation. Bone marrow transplant 1998; 21: 167–171.
Lee J, Kook H, Chung I, Kim H, Park M, Kim C et al. Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone marrow transplant 1999; 24: 411–415.
Rufer N, Brummendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E . Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 2001; 97: 575–577.
de Pauw ES, Otto SA, Wijnen JT, Vossen JM, van Weel MH, Tanke HJ et al. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion. Br j haematol 2002; 116: 491–496.
Baerlocher GM, Rovo A, Muller A, Matthey S, Stern M, Halter J et al. Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex. Blood 2009; 114: 219–222.
Sottini A, Ghidini C, Zanotti C, Chiarini M, Caimi L, Lanfranchi A et al. Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin immunol 2010; 136: 217–227.
Cawthon RM . Telomere measurement by quantitative PCR. Nucleic acids res 2002; 30: e47.
Gertow J, Berglund S, Okas M, Uzunel M, Berg L, Karre K et al. Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation. Clin exp immunol 2010; 162: 146–155.
Storek J, Joseph A, Espino G, Dawson MA, Douek DC, Sullivan KM et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 2001; 98: 3505–3512.
Nakatani K, Imai K, Shigeno M, Sato H, Tezuka M, Okawa T et al. Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation. Bone marrow transplant 2014; 49: 1155–1161.
Przybylski GK, Kreuzer KA, Siegert W, Schmidt CA . No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GvHD. J appl genet 2007; 48: 397–404.
Storek J, Wells D, Dawson MA, Storer B, Maloney DG . Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001; 98: 489–491.
Abrahamsen IW, Somme S, Heldal D, Egeland T, Kvale D, Tjonnfjord GE . Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 2005; 90: 86–93.
Sairafi D, Mattsson J, Uhlin M, Uzunel M . Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival. Clin immunol 2012; 142: 343–350.
Geyer MB, Jacobson JS, Freedman J, George D, Moore V, van de Ven C et al. A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. Br j haematol 2011; 155: 218–234.
Ferrara JL, Reddy P . Pathophysiology of graft-versus-host disease. Semin hematol 2006; 43: 3–10.
Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J immunol methods 2010; 352: 71–80.
Lin J, Cheon J, Brown R, Coccia M, Puterman E, Aschbacher K et al. Systematic and cell type-specific telomere length changes in subsets of lymphocytes. J immunol res 2016; 2016: 5371050.
Aubert G, Hills M, Lansdorp PM . Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat res 2012; 730: 59–67.
Acknowledgements
This study was supported by Swedish research Council, Swedish Society for Childhood cancer and Stockholm county Council.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Gaballa, A., Norberg, A., Stikvoort, A. et al. Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients. Bone Marrow Transplant 53, 69–77 (2018). https://doi.org/10.1038/bmt.2017.216
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.216